Introduction
Methods
Search strategy
Inclusion and exclusion criteria
-
Published in English between 1946 and April 2019
-
Evaluated one or more of the following self-initiated self-management behaviors that were identified in the available literature for PN: meditation, cold therapy, heat therapy, magnet therapy, massage, exercise, walking, rest, or TENS
-
Included people with symptomatic PN from diabetes (DPN), HIV, chemotherapy-induced peripheral neuropathy (CIPN), chronic inflammatory demyelinating neuropathy (CIDN), and autoimmune disorders
-
Used an experimental study design (RCT, non-RCT, and quasi-experimental studies)
-
Included adult patients
-
Evaluated any of the following self-reported outcomes associated with the self-management intervention for PN: pain, numbness, tingling, and/or allodynia associated with PN and quality of life
-
Could only be performed under the direction of clinicians or other health professionals (i.e., were not self-initiated)
-
Involved the ingestion of pharmacological, herbal, or other substances as these would require clinician input to assess for interaction with the medications used in the treatment of their medical condition
-
Occurred with patients who had PN arising from trauma or other conditions not listed in the inclusion criteria
Search terms
Screening and data extraction
Type of intervention | First author (year) | Design | Cause of PN | Grade of PN | No. of subjects | Age (years) (M, SD) | Female | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
IG | CG | IG | CG | |||||||||
Hot bath/massage | Park and Park (2015) [59] | Experimental | CIPN | Grade II = 58.3% Grade III = 41.7% | 24 | 24 | 57.08, 11.52 | 60.79, 8.97 | 37.5 | |||
Meditation | Clark et al. (2012) [60] | RCT | CIPN | Not specified | A 7 | B 7 | C 5 | D 7 | 59.04, 8.56 | 88.5 | ||
Nathan et al. 2017 [63] | RCT | CIPN | M = 5.1 (SD = 1.3) on BPI | 30 | 32 | 59.7, 9.1 | 59.8, 8.7 | 56 | ||||
Teixeira (2010) [62] | RCT | CIPN | Not specified | 10 | 10 | 74.6, 10.8 | 75 | |||||
Exercise | Ahn and Song (2012) [67] | Experimental | DPN | Not specified | 20 | 19 | 66.05, 6.42 | 62.73, 7.53 | 48.7 | |||
Dixit et al. (2014) [66] | RCT | DPN | Minimum score of 7 on MDNS | 29 | 37 | 54.40, 1.24 | 59.45, 1.16 | 43.6 | ||||
Kluding et al. (2012) [64] | Experimental | DPN | Not specified | 17 | 58.4, 5.98 | 53 | ||||||
McCrary et al. (2019) [68] | Experimental | CIPN | ≥ 2 on CTCAE v.4.03 | 29 | 61.6 (M), 32–79 (range) | 72.4 | ||||||
Ruhland and Shields (1997) [65] | Experimental | CIDN | Not specified | 14 | 14 | 63.6, 10.5 | 52.9, 16.2 | 32 | ||||
Yoo et al. (2015) [61] | Experimental | DPN | Not specified | 14 | 57, 5.11 | 64.3 | ||||||
TENS | Forst et al. (2004) [70] | RCT | DPN | ≥ 4 and ≤ 16 on NTSS-6 | 12 | 7 | 57.6, 11.5 | 59.4, 8.6 | 47 | |||
Gewandter et al. (2018) [72] | Experimental | CIPN | ≥ 4 on NRS 1–10 | 22 | Mdn 56, IQR 53–63 | 59 | ||||||
Kumar & Marshall (1997) [69] | RCT | DPN | Not specified | 18 | 13 | 53, 4 | 59, 3 | 61 | ||||
Reichstein et al. (2005) [74] | RCT | DPN | TSS: HF M = 7.0, SD = 3.6 TENS M = 6.6, SD = 3.2 | HF 20 | TENS 21 | HF 64.2, 12.7 | TENS 57.8, 12.5 | 43.2 | ||||
Serry et al. (2015) [71] | RCT | DPN | Not specified | A 20 | B 20 | C 20 | A 51.6, 4.75 | B 51.7, 4.44 | C 51.7, 4.44 | 53 | ||
Tonezzer et al. (2017) [73] | RCT | CIPN | Grade I or II on CTCAE | 11 | 13 | 52.7, 9.0 | 46.3, 13.7 | 20.8 |
First author (year) | Purpose and intervention | Outcome measures | Main findings |
---|---|---|---|
Ahn and Song (2012)[67] | Purpose: Determine the effects of tai chi exercise on glucose control, neuropathy scores, balance, and quality of life in patients with diabetic PN. Intervention: 1 h of tai chi per session, twice a week for 12 weeks. Control: Usual care | Total Symptom Score (TSS) questionnaire | Differences in pre- and post-test mean TSS indicated significant symptom improvement in the intervention group (mean change from M = 1.13, SD = 1.95 to M = 0.91, SD = 1.87 vs M = 1.19, SD = 1.98 to M = 2.83, SD = 3.29 for the controls, p = 0.042). |
Reichstein et al. (2005)[74] | Purpose: Compare the effects of high-frequency muscle stimulation (HF) with TENS therapy in patients with diabetic PN. HF group received HF for 30 min for 3 consecutive days. TENS group received TENS therapy for 30 min for 3 consecutive days. | Total Symptom Score (TSS) questionnaire | Differences in pre- and post-test mean TSS indicated significant symptom improvement in both groups: HF group mean reduced from M = 7.0, SD = 3.6 to M = 4.6, SD = 3.4, (p < 0.005); TENS group M = 6.6, SD = 3.2 to M = 5.4, SD = 3.8, (p < 0.05). |
Dixit et al. (2014)[66] | Purpose: Evaluate the effect of an 8-week moderate-intensity aerobic (heart-rate reserve 40–60%) exercise program on neuropathy-related quality of life in people with diabetic PN. Intervention: Exercise training in the range of 40–60% of heart-rate reserve (HRR) within a rating of perceived exertion (RPE) (scale ranging from 6 to 20). Delivered 5–6 days of the week for 8 weeks, accumulating a minimum of 150 min/week to a maximum of 360 min/week. Control: Standard medical care, education for foot care and diet | Michigan Diabetic Neuropathy Score (MDNS) | Mean MDNS score significantly reduced across sensory, motor, and reflex subsets for the intervention group between baseline and the 8th week (M = 12.57, SD = 1.74, 95% CIs [13.11–12.03] reduced to M = 7.03, SD = 1.86, 95% CIs [7.61–6.45], p < 0.001), in comparison to an increase in the control group (M = 13.55, SD = 1.75, 95% CIs [14.05–13.05], increased to M = 14.57, SD = 1.50, 95% CIs [15–14.09], p < 0.001), indicating an improvement in PN symptoms in the intervention group. |
Kluding et al. (2012)[64] | Purpose: Examine the feasibility of a supervised, moderately intense aerobic and resistance exercise program in people with diagnosed diabetic PN. Intervention: A 10-week exercise program with both aerobic and strengthening elements, 3 to 4 times per week. Control: None | Michigan Neuropathy Screening Instrument (MNSI) symptom questionnaire | Overall mean MNSI symptom score decreased significantly (M = 5.24, SD = 1.4 pre-intervention to M = 4.00, SD = 2.00 post-intervention, p = 0.01), indicating an improvement in PN symptoms. |
Gewandter et al. (2018)[72] | Purpose: Inform a future randomized phase 2 study and determine if TENS has the potential to improve CIPN. Intervention: Wireless TENS therapy for at least 1 h twice per day for a 6-week period. Control: None | European Organization for Research and Treatment of Cancer-CIPN20 (EORTC-CIPN20) | EORTC-CIPN20 median baseline scores reduced from 39.5 (IQR 31–47.3) to Mdn 34.5 (IQR 28.8–41.8, p = 0.004) post-TENS intervention, indicating and improvement in PN symptoms. Median SF-MPQ-2 scores reduced from baseline Mdn 60.5 (IQR 21.8–88.5) to a post-intervention Mdn 29 (IQR 8.8–63.8) (p < 0.001), indicating an improvement in self-reported pain of 52%. |
McCrary et al. (2019)[68] | Purpose: Evaluate the impact of a multimodal exercise intervention on CIPN symptoms, functional deficits, and neurophysiologic parameters. Intervention: An 8-week exercise intervention with resistance, balance, and cardio elements, 3 times per week. Control: An 8-week pre-intervention control period | CIPN symptom severity (European Organization for Research and Treatment of Cancer [EORTC] CIPN 20); Overall Disability (CIPN Rasch Built overall disability score [CIPN-R-ODS]) | Significant reduction in CIPN symptoms (CIPN-20 score) (M = 25.4, SE = 3.0 pre-exercise to M = 18.5, SE = 2.3 post-exercise, p < 0.001); Significant improvement in function according to CIPN-R-ODS (M = 79.9, SE = 2.7 pre-exercise to M = 83.2, SE = 2.4 post-exercise, p = 0.04). |
Tonezzer et al. (2017)[73] | Purpose: Evaluate the effects of TENS on CIPN symptoms. Intervention group: 60 min of TENS daily for 45 days. Control: As with intervention with a sham machine | Visual Analogue Scale (VAS) assessing pain and other neuropathy-related symptoms. Chemotherapy-Induced Neurotoxicity Questionnaire (CINQ) to evaluate frequency of symptoms and interferences with daily activities | No significant findings on VAS or CINQ |
First author (year) | Purpose and intervention | Outcome measures | Main findings |
---|---|---|---|
Nathan et al. (2017)[63] | Purpose: Evaluate the effectiveness of community-based mindfulness-based stress reduction (MBSR) courses to improve physical and mental functioning among patients with PDPN whose medical treatment has been optimized. Intervention: Nine sessions of MBSR: eight weekly, 2.5-h sessions and one 6-h session on a weekend day midway through the course. Control: Usual activities, offered the opportunity to enroll in a MBSR course once the study was complete | Brief Pain Inventory (BPI) score | BPI Pain Severity mean score decreased in the MBSR group (M = − 1.59, 95% CIs [− 2.29 to − 0.90]) between baseline and week 12, compared to the control group (M = 0.33, 95% CIs [− 0.12 to 0.78], p < 0.001), indicating a reduction in pain in the intervention group. |
Yoo et al. (2015)[61] | Purpose: Explore the effect of a supervised, moderate-intensity aerobic exercise training intervention on pain and pain interference in daily life, specifically in people with DPN. Intervention: 16 weeks of supervised aerobic exercise 3 times a week, of 30 to 50 min duration. Control: None | Various measures of pain and pain interference using the Brief Pain Inventory Short Form for Diabetic Peripheral Neuropathy (BPI-DPN) and a questionnaire devised by the authors. | Significant reductions in pain interference observed with walking on mean BPI-DPN score (M = 4.93, SD = 3.03 pre to M = 3.29, SD = 2.89 post, p = 0.016), normal work (M = 5.39, SD = 3.32 pre to M = 3.79, SD = 3.04 post, p = 0.032), relationships with others (M = 3.96, SD = 3.53 pre to M = 1.29, SD = 1.27 post, p = 0.006), sleep (M = 5.11, SD = 3.04 pre to M = 3.50, SD = 3.03 post, p = 0.02), and overall pain interference (M = 4.65, SD = 2.70 pre to M = 2.97, SD = 2.22 post, p = 0.013). |
Kluding et al. (2012)[64] | Purpose: Examine the feasibility of a supervised, moderately intense aerobic and resistance exercise program in people with diagnosed diabetic PN. Intervention: 10-week exercise program with both aerobic and strengthening elements, 3 to 4 times per week. Control: None | Michigan Neuropathy Screening Instrument (MNSI) symptom questionnaire | Worst pain MNSI mean score decreased (M = 62.4, SD = 26.7 pre-intervention to M = 44.3, SD = 35.1 post-intervention, p = 0.05). |
Forst et al. (2004)[70] | Purpose: Investigate the efficacy and safety of the Salutaris (TENS) device in patients suffering from symptomatic diabetic neuropathy. Intervention: TENS therapy over 12 weeks, self-administered for at least 30 min per day. Control: Electrically inactive (sham) device | Various pain qualities were measured by the Neuropathy Total Symptom Score-6 (NTSS-6), i.e., lancinating, burning, and aching pain, numbness, prickling sensation, and allodynia; pain intensity measured using a Visual Analogue Scale (VAS). | Active TENS treatment resulted in a significant improvement in mean NTSS-6 score after 6 weeks (− 42%) and after 12 weeks (− 32%) of treatment (baseline M = 10.0, SD = 3.3, 6 weeks M = 5.8, SD = 5.0 (p < 0.05), 12 weeks M = 6.8, SD = 3.9, p = 0.05), in comparison to the control group (baseline M = 7.6, SD = 3.1; 6 weeks M = 8.1, SD = 5.1, (n.s.), 12 weeks M = 6.5, SD = 6.1 [n.s.]). Improvement in mean sub-NTSS scores within the intervention group, including numbness (M = 2.19, SD = 1.05 to M = 1.55, SD = 1.26; p < 0.05); lancinating pain (M = 1.58, SD = 1.09 to M = 0.58, SD = 0.86; p < 0.05) and allodynia (M = 1.44, SD = 1.59 to M = 0.53, SD = 1.03; p < 0.05). The intervention group also reported a significant improvement in intervention group mean VAS score after 6 weeks of TENS therapy (M = 19.8, SD = 5.0 to M = 14.4, SD = 9.6; p < 0.05), while no change was observed in the control group. |
Kumar and Marshall (1997)[69] | Purpose: Evaluate the efficacy of transcutaneous electrotherapy for chronic painful peripheral neuropathy in patients with type 2 diabetes. Intervention: TENS therapy over 4 weeks, self-administered for 30 min per day. Control: Electrically inactive (sham) device | Grading of pain intensity on a 0–5-point scale; perception of pain using a VAS | Significant reduction in pain grading for those in the intervention group, with the intervention group mean score declining from M = 3.17, SD = 0.12 to M = 1.44, SD = 0.25 (p < 0.01). Significant reduction also reported in the control group, with group mean score declining from M = 2.92, SD = 0.13 to M = 2.38, SD = 0.26 (p = 0.04). Intervention group reported greater reductions in pain through the VAS (M = 52, SD = 7) compared with the control group (M = 27, SD = 10, p < 0.05). |
Serry et al. (2015)[71] | Purpose: To investigate the efficacy of TENS versus aerobic exercise and to compare them with regular pharmacological therapy in patients with diabetic PN. Group A: Received TENS therapy for 30 min 3 times per week for 8 weeks in addition to regular pharmacological therapy for PN. Group B: Engaged in aerobic exercise for 30 min 3 times for week for 8 weeks in addition to regular pharmacological therapy for PN. Group C: Received only regular pharmacological therapy for PN and oral hypoglycemic drugs or insulin. | Pain intensity evaluated using a VAS. | Compared to pharmacologic management, both the TENS and exercise groups had significant reductions in mean VAS pain score (TENS group 41.6% reduction, exercise group 16.7% reduction, p < 0.05). Group C (pharmacological management) showed no significant reductions in pain intensity. |
Reichstein et al. (2005)[74] | Purpose: To compare the effects of high-frequency muscle stimulation (HF) with TENS therapy in patients with diabetic PN. HF group received HF for 30 min for 3 consecutive days. TENS group received TENS therapy for 30 min for 3 consecutive days. | 1–10 point Numerical Rating Scale (NRS) for pain, numbness, burning, parasthesias; or dysesthesia taken at baseline, after all treatment days and 2 days post-intervention. | Reductions in NRS pre and post both interventions; 7 out of 21 patients (33%) in the TENS group and 16 out of 20 patients (80%) in the HF group reported improvement in pain symptoms (p < 0.05). HF more effective than TENS therapy in patients with nonpainful DPN (HF—100%, 7 out of 7; TENS—44%, 4 out of 9; p < 0.05), and in patients with painful DPN (HF—69%, 9 out of 13; TENS—25%, 3 out of 12; p < 0.05). |
Gewandter et al. (2018)[72] | Purpose: To inform a future randomized phase 2 study and determine if TENS has the potential to improve CIPN. Intervention: Wireless TENS therapy for at least 1 h twice per day for a 6-week period. Control: None | Short Form McGill Pain Questionnaire-2 (SF-MPQ-2); daily diary containing NRS from 0 to 10 for pain, numbness, tingling, and cramping | NRS median scores indicated reduced pain symptoms post-TENS: pain reduced from a baseline median of 6 (IQR 1.8–6.6) to Mdn 3.7 (IQR 0.42–5.5, p < 0.001), tingling reduced from a baseline median of 5.7 (IQR 4.1–7.1) to Mdn 4 (IQR 1.8–5.1, p = 0.002) post-intervention, numbness from baseline median of 5.5 (IQR 4.7–6.6) to Mdn 4.4 (IQR 3.0–5.2, p < 0.001) post-intervention, and cramping from baseline median 3.0 (IQR 0.3–5.8) to Mdn 1.4 (IQR 0.0–3.1, p < 0.001) post-intervention. |
Tonezzer et al. (2017)[73] | Purpose: To evaluate the effects of TENS on CIPN symptoms. Intervention group: 60 min of TENS daily for 45 days. Control: As with intervention with a sham machine | VAS assessing pain and other neuropathy-related symptoms | No significant findings on VAS |
Teixeira (2010)[62] | Purpose: The purpose of this pilot study was to evaluate the effectiveness of mindfulness meditation on QoL among adults living with symptomatic diabetic PN. Intervention: The treatment group received instruction in mindfulness meditation and were instructed to listen to guided CD 5 days per week over a 4-week period. Control: Nutritional advice and asked to maintain a food diary for 4 weeks | Pain level using Neuropathic Pain Scale (NPS) | No statistically significant differences between the groups’ post-intervention scores on the NPS |
First author (year) | Purpose and intervention | Outcome measures | Main findings |
---|---|---|---|
Clark et al. (2012)[60] | Purpose: Determine the feasibility of using 3 complementary interventions in relieving the physical and emotional symptoms associated with CIPN while increasing capacity for mindfulness or self-focused attention. Intervention: A. Reiki intervention (n = 7)—up to 5 sessions over a 6-week period B. Yoga intervention (n = 7)—weekly session over 6 weeks C. Meditation intervention (n = 5)—weekly session over 6 weeks Control: One hour holistic education weekly for 6 weeks | Quality of life and PN using the Functional Assessment of Cancer Therapies—Gynecologic Group—Neurotoxicity Scale (FACT/GOG-NTx) | No significant difference between intervention groups on FACT/GOG-NTx. Subjects in the control group demonstrated significantly higher levels of neurotoxicity related QoL according to mean FACT/GOG-NTx score (M = 31.14, SD = 8.47 pre-test, M = 27.86, SD = 9.82 post-test, p = 0.037). |
Park and Park (2015)[59] | Purpose: Analyze the effects of foot bathing and massage in patients with CIPN. Intervention group: One 30-min foot bath (temp 40 °C) session every other day, totaling 8 times over 2 weeks. Control: 30 min general massage sessions every other day, for a total of 8 times over 2 weeks | Quality of life (QoL) assessed using Functional Assessment of Cancer Therapy-General (FACT-G) and Functional Assessment of Cancer Therapy/Gynecologic Oncology Group/Neurotoxicity (FACT/GOG-NTx) | QoL (mean FACT-G score) increased in the foot bath group post-intervention (M = 62.75, SD = 11.29 pre-intervention vs M = 65.33, SD = 12.96 post-intervention, p = 0.028). Significant decrease in QoL in the foot massage group post-intervention (M = 59.63, SD = 12.47 pre-intervention vs M = 53.33, SD = 11.09 post-intervention, p = 0.042). QOL related to the symptoms (mean FACT-NTx score) in the foot bath group increased over time (M = 26.79, SD = 4.81 pre-intervention vs M = 31.13, SD = 5.57 post-intervention, p < 0.001), in comparison to QoL in the foot massage group which decreased over time (M = 29.42, SD = 7.82 pre-intervention vs M = 26.38, SD = 7.75 post-intervention, p < 0.001). |
Dixit et al. (2014)[66] | Purpose: Evaluate the effect of 8-week moderate-intensity aerobic (heart-rate reserve 40–60%) exercise on neuropathy quality of life in people with diabetic PN. Intervention: Exercise training in the range of 40–60% of heart-rate reserve (HRR) within a rating of perceived exertion (RPE) (scale ranging from 6 to 20). Delivered 5–6 days of the week for 8 weeks, accumulating a minimum of 150 min/week to a maximum of 360 min/week. Control: Standard medical care, education for foot care and diet | Neuropathy quality of life (NQOL) score | Intervention group reported a reduction in mean NQOL score (M = 32.85, SD = 1.32, 95% CIs [33.28–32.42], decreased to M = 24.41, SD = 1.12, 95% CIs [24.82–24.00]), while the control group reported an increase in mean NQOL score (M = 33.55, SD = 1.37, 95% CIs [33.95–33.15], increased to M = 34.16, SD = 1.37, 95% CIs [34.61–33.71], p < 0.001) |
Nathan et al., (2017)[63] | Purpose: Evaluate the effectiveness of community-based mindfulness-based stress reduction (MBSR) courses to improve physical and mental functioning among patients with PDPN whose medical treatment has been optimized. Intervention: Nine sessions of MBSR: eight weekly, 2.5-h sessions and one 6-h session on a weekend day midway through the course. Control: Usual activities, offered the opportunity to enroll in a MBSR course once the study was complete | Patient Global Impression of Change (PGIC) for QoL; Short Form-12 Health Survey version 2 (SF-12); Neuropathy-Specific Quality of Life Questionnaire (NQoL) | 14 of 30 in the MBSR group (46.7%) compared to 2 of 32 in the control group (6.2%) reported improvements in mean PGIC score at the 12-week follow-up (adjusted OR 18.8, 95% CIs [2.3–151.5], p = 0.007), indicating that they perceived an increase in general well-being. The MBSR group mean NQoL score indicated higher quality of life related to pain between baseline and week 12 (M = − 1.39, 95% CIs [− 2.16 to − 0.61]), compared to the control group (M = 0.90, 95% CIs [− 0.53 to 2.33], p = 0.006). All SF-12 subscale mean scores indicated improvement in reported symptoms for the MBSR group, with the exception of vitality and role emotion (p < 0.05). |
McCrary et al. (2019)[68] | Purpose: Evaluate the impact of a multimodal exercise intervention on CIPN symptoms, functional deficits, and neurophysiologic parameters. Intervention: 8-week exercise intervention with resistance, balance, and cardio elements, 3 times per week. Control: 8-week pre-intervention control period | Quality of Life (QoL) (SF-36) | Significant improvement in QoL (SF-36) (M = 60.5, SE = 3.7 pre-exercise to M = 69.1, SE = 3.6 post-exercise, p = 0.003) |
Ruhland and Shields (1997)[65] | Purpose: Examine the effects of a home exercise program on PN impairment and QoL. Intervention: Exercise with Thera-Bands and cycling or walking for 10 to 20 min, over 6 weeks. Control: Maintain current levels of activity | Medical Outcomes Study (MOS) 36-Item Short-Form Health Survey (SF-36) | Significant improvement within the role limitation (physical) dimension of the SF-36, with mean scores increasing from M = 28.6 pre-test to M = 53.6 post-test (p = 0.007) for the exercise group compared to M = 55.4 pre-test to M = 62.5 (n.s.) for the control group. |
Ahn and Song (2012)[67] | Purpose: Determine the effects of tai chi exercise on glucose control, neuropathy scores, balance, and quality of life in patients with diabetic PN. Intervention: One hour of tai chi per session, twice a week for 12 weeks. Control: Usual care | Subjective: Korean version of the SF-36v2 (36-Item Short Form Health Survey version 2) | Significant improvement in mean SF-36v2 score for several subsets including physical function (p = 0.028), bodily pain (p = 0.009), physical role limitation (p = 0.006), emotional role limitation (p = 0.002), and social functioning (p = 0.001) |
Teixeira (2010)[62] | Purpose: Evaluate the effectiveness of mindfulness meditation on quality of life among adults living with symptomatic diabetic PN. Intervention: Treatment group received instruction in mindfulness meditation and were instructed to listen to guided CD 5 days per week over a 4-week period. Control: Nutritional advice and asked to maintain a food diary for 4 weeks | Quality of life using NQoL | No significant differences for adjusted overall QoL; symptom-related QoL; emotion-related QoL; sensory-motor related QoL; pain QoL |
First author (year) | Purpose and intervention | Outcome measures | Main findings |
---|---|---|---|
Nathan et al. (2017)[63] | Purpose: Evaluate the effectiveness of community-based mindfulness-based stress reduction (MBSR) courses to improve physical and mental functioning among patients with PDPN whose medical treatment has been optimized. Intervention: Nine sessions of MBSR: eight weekly, 2.5-h sessions and one 6-h session on a weekend day midway through the course. Control: Usual activities, offered the opportunity to enroll in a MBSR course once the study was complete. | Glycosylated hemoglobin (HbA1c) measurement; Patient Health Questionnaire-9 (PHQ-9) for depression; Profile of Mood States-2A (POMS-2A) for total mood disturbance; Perceived Stress Scale (PSS); Pain Catastrophizing Scale (PCS) | Mean PCS score decreased in the MBSR group (− 10.67, 95% CIs [− 14.38 to − 6.95]), between baseline and week 12, compared to the control group (1.69, 95% CIs [− 1.47 to 4.85], p < 0.001). Mean PHQ-9 score significantly reduced in the MBSR group (M = − 4.75, 95% CIs [− 6.55 to − 2.96], p < 0.001), between baseline and week 12, compared to the control group (M = 0.06, 95% CIs [− 1.66 to 1.53], p < 0.001). The MBSR group mean PSS reduced between baseline and week 12 (M = − 4.64, 95% CIs [− 7.89 to − 1.38], p = 0.001), compared to the control group (M = 1.75, 95% CIs [− 0.14 to 3.64], p = 0.001). |
Clark et al. (2012)[60] | Purpose: Determine the feasibility of using 3 complementary interventions in relieving the physical and emotional symptoms associated with CIPN while increasing the capacity for mindfulness or self-focused attention. Intervention: D. Reiki intervention (n = 7)—up to 5 sessions over a 6-week period E. Yoga intervention (n = 7)—weekly session over 6 weeks F. Meditation intervention (n = 5)—weekly session over 6 weeks Control: 1 h holistic education weekly for 6 weeks | Psychological distress using the Brief Symptom Inventory (BSI); Mindfulness using the Mindful Awareness Attention Scale (MAAS). | No significant difference between groups on BSI and MAAS |
Ahn and Song (2012)[67] | Purpose: Determine the effects of tai chi exercise on glucose control, neuropathy scores, balance, and quality of life in patients with diabetic PN. Intervention: Standardized tai chi for diabetes of 1 h of tai chi per session, twice a week for 12 weeks. Control: Usual care | Fasting blood sugar (FBS); HbA1c; Semmes–Weinstein 10-g monofilament examination scores (SWME); single leg stance for balance. | Mean FBS reduced in the intervention group (M = 137.85 mg/dL, SD = 45.19 to 125.5 mg/dL, SD = 45.57, p = 0.036) compared to the control group (M = 143.47 mg/dL, SD = 47.45 to 155.31 mg/dL, SD = 44.88, p = 0.036). A significant difference was seen in HbA1c levels post-intervention in the tai chi group (M = 7.20, SD = 1.32, p = 0.004) compared to the control group (M = 8.32, SD = 1.76, p = 0.004). Differences in pre- and post-test balance mean scores indicated significant improvement in balance for the tai chi group (M = − 7.65, SD = 16.78, p = 0.044), compared to the control group (M = 1.44, SD = 9.97, p = 0.044). The SWME identified no significant changes in peripheral sensory function pre- and post-test. |
Kluding et al. (2012)[64] | Purpose: Examine the feasibility of a supervised, moderately intense aerobic and resistance exercise program in people with diagnosed diabetic PN. Intervention: 10-week exercise program with both aerobic and strengthening elements, 3 to 4 times per week. Control: None | BMI; Resting heart rate (RHR) Glycosylated hemoglobin (HbA1c); Michigan Neuropathy Screening Instrument (MNSI) physical exam score; Nerve conduction studies (NCS); Quantitative Sensory Testing (QST); intraepidermal nerve fiber density (IENF) | Significant reduction in HbA1c (M = 7.8, SD = 1.0 pre-intervention to M = 7.28, SD = 0.83 post-intervention, p = 0.031). Significant increase in IENF branching at the proximal biopsy site (M = 0.16, SD = 0.15 pre-intervention to M = 0.27, SD = 0.19 post-intervention, p = 0.008). Significant reduction in RHR (M = 77.3, SD = 8.2 pre-intervention to M = 72, SD = 9.6 post-intervention, p = 0.036). No significant difference in NCS or QST |
Ruhland and Shields (1997)[65] | Purpose: Examine the effects of a home exercise program on PN impairment and quality of life. Intervention: Exercise with Thera-Bands and cycling or walking for 10 to 20 min, over 6 weeks. Control: Maintain current levels of activity | Average Muscle Score (AMS); handgrip force; forced vital capacity (FVC); timed 9.1 m walk | Significant improvement in mean AMS in exercise group (pre-test M = 8.8, post-test M = 9.2, p = 0.002); significant improvement in handgrip force (pre-test M = 28.6, post-test M = 30.8, p = 0.033) |
Yoo et al. (2015)[61] | Purpose: Explore the effect of a supervised, moderate-intensity aerobic exercise training intervention on pain and pain interference in daily life, specifically in people with DPN. Intervention: 16 weeks of supervised aerobic exercise 3 times a week, of 30 to 50 min duration. Control: None | Objective: body mass index (BMI); aerobic fitness (VO2max); blood pressure; glycemic control (hemoglobin A1c) | No significant changes were found for BMI, blood pressure, or glycemic control. Significant improvement in mean maximum oxygen uptake (VO2max) (mL/kg/min) (M = 16.02, SD = 3.84 pre to M = 17.18, SD = 4.19 post, p = 0.028). |
Gewandter et al. (2018)[72] | Purpose: To inform a future randomized phase 2 study and determine if TENS has the potential to improve CIPN. Intervention: Wireless TENS therapy for at least 1 h twice per day for a 6-week period. Control: None | Objective: Utah Early Neuropathy Score (UENS); forced choice monofilament test | No significant improvements with UENS; monofilament test reported sensation threshold improved in 10 of 16 (63%; 95% CI [35–85%], p < 0.0001) participants who completed the test. |
Serry et al. (2015)[71] | Purpose: To investigate the efficacy of TENS versus aerobic exercise, and to compare them with regular pharmacological therapy in patients with diabetic PN. Group A: Received TENS therapy for 30 min 3 times per week for 8 weeks in addition to regular pharmacological therapy for PN. Group B: Engaged in aerobic exercise for 30 min 3 times for week for 8 weeks in addition to regular pharmacological therapy for PN. Group C: Received only regular pharmacological therapy for PN and oral hypoglycemic drugs or insulin. | Nerve conduction studies (NCS) to measure medial plantar sensory nerve conduction velocity (SCV) | No significant differences in SCV between pre- and post-test measurements for any of the groups, or between the groups |
McCrary et al. (2019)[68] | Purpose: Evaluate the impact of a multimodal exercise intervention on CIPN symptoms, functional deficits and neurophysiologic parameters. Intervention: 8-week exercise intervention with resistance, balance, and cardio elements, 3 times per week. Control: 8 week pre-intervention control period | Objective: Total Neuropathy Score Clinical version (TNSc); mobility (6 min timed walk); standing balance (Swaymeter); lower limb strength and dynamic balance (5 times sit to stand test) | Significant reduction in TNSc symptom score (M = 7.0, SE = 0.7 pre-exercise to M = 5.3, SE = 0.5 post-exercise, p = 0.001); significant increase in distance in 6 min walk test (m) (M = 452.1, SE = 17.4 pre-exercise to M = 469.9, SE = 20.9 post-exercise, p = 0.02); significant reduction in 5 times sit to stand time (s) (M = 13.1, SE = 0.8 pre-exercise to M = 11.8, SE = 0.6 post-exercise, p = 0.03); significant reduction in postural sway (mm) on a stable surface eyes open (M = 140.9, SE = 23.6 pre-exercise to M = 104.2, SE = 13.6 post-exercise, p = 0.006) |